about A Statement from Executive Director, Lisa Butler, with regard to COVID-19 and Planning Ahead
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19Read More about Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
By Dr. David Saperstein Antibodies (also known as immunoglobulins) play an important role in health and illness. Many of you regularly receive intravenous immunoglobulin (IVIG) to treat your autoimmune disease. Flooding a person’s system with antibodies from normal, healthy individuals can reverse problems caused by abnormally overactive immune systems. However, providing antibodies that fight a specific infection can…Read More about What is Convalescent Plasma?
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19.Read More about Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Patient groups praise U.S. guidelines that designate plasma centers, manufacturing sites as essential. See full articleRead More about Work Continues for CSL Behring During the Pandemic
Earlier this week, the Center for Medicare and Medicaid Services (CMS) released new guidelines for the coverage of home infusion during the COVID-19 pandemic. The new guidelines allow for more flexibility for patients and their physicians to decide the best setting for ongoing treatments. Given your current situation, you may be able to access home…Read More about Update on Home Infusion & Medicare During COVID-19 Pandemic